An improved ileal conduit surgery for bladder cancer with fewer complications

Abstract Background Radical cystectomy and urinary diversion remains the standard surgical treatment for patients with muscle-invasive or high-risk or recurrent non-muscle-invasive bladder cancer. Although this approach prolongs patient survival remarkably, there are postoperative complications asso...

Full description

Bibliographic Details
Main Authors: Zhiyong Li, Zhuowei Liu, Kai Yao, Zike Qin, Hui Han, Yonghong Li, Pei Dong, Yunlin Ye, Yanjun Wang, Zhiming Wu, Zhiling Zhang, Fangjian Zhou
Format: Article
Language:English
Published: Wiley 2019-04-01
Series:Cancer Communications
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40880-019-0366-8
_version_ 1818281516211372032
author Zhiyong Li
Zhuowei Liu
Kai Yao
Zike Qin
Hui Han
Yonghong Li
Pei Dong
Yunlin Ye
Yanjun Wang
Zhiming Wu
Zhiling Zhang
Fangjian Zhou
author_facet Zhiyong Li
Zhuowei Liu
Kai Yao
Zike Qin
Hui Han
Yonghong Li
Pei Dong
Yunlin Ye
Yanjun Wang
Zhiming Wu
Zhiling Zhang
Fangjian Zhou
author_sort Zhiyong Li
collection DOAJ
description Abstract Background Radical cystectomy and urinary diversion remains the standard surgical treatment for patients with muscle-invasive or high-risk or recurrent non-muscle-invasive bladder cancer. Although this approach prolongs patient survival remarkably, there are postoperative complications associated with urinary diversion. This study aimed to assess the efficacy of modified ileal conduit surgery for reducing early and late stoma- and ureteroileal anastomosis-related complications, as compared with conventional ileal conduit urinary diversion. Methods We retrospectively evaluated the clinical data of bladder cancer patients treated with radical cystectomy and ileal conduit urinary diversion at Sun Yat-sen University Cancer Center between January 1, 2000 and June 30, 2016. Ileal conduit was created by the conventional or a modified technique. The clinicopathologic features of the conventional and the modified ileal conduit groups were compared using the t test and the Chi square test. Multivariable logistic regression analysis and multivariable Cox regression analysis were performed to determine the odds of developing stoma- and ureteroileal anastomosis-related complications in the two groups. Results 145 and 100 patients underwent the modified and conventional ileal conduit surgery, respectively. The two groups were comparable with regard to clinicopathologic features. The rate of stoma-related complications was significantly lower in the modified ileal conduit group than in the conventional ileal conduit group (0.7% vs. 17.0%, P < 0.001). No late stoma-related complications were seen in the modified ileal conduit group, but were seen in 13 (13.0%) patients in the conventional ileal conduit group. The rate of ureteroileal anastomosis-related complications was significantly lower in the modified ileal conduit group than in the conventional ileal conduit group (4.8% vs. 15.0%, P = 0.001). In multivariable analyses, the modified ileal conduit group was significantly less likely to develop stoma- (odds ratio [OR] = 0.024, 95% confidence interval [CI] 0.003–0.235; P = 0.001) or ureteroileal anastomosis-related complications (OR = 0.141, 95% CI 0.042–0.476; P = 0.002) than the conventional ileal conduit group. Conclusions Our modified surgical technique for ileal conduit urinary diversion may be effective for reducing early and late complications related to the stoma and the ureteroileal anastomosis. Prospective randomized clinical trials are needed to confirm our results.
first_indexed 2024-12-13T00:06:21Z
format Article
id doaj.art-d3530276738944debe54c2b0e253b732
institution Directory Open Access Journal
issn 2523-3548
language English
last_indexed 2024-12-13T00:06:21Z
publishDate 2019-04-01
publisher Wiley
record_format Article
series Cancer Communications
spelling doaj.art-d3530276738944debe54c2b0e253b7322022-12-22T00:06:15ZengWileyCancer Communications2523-35482019-04-0139111010.1186/s40880-019-0366-8An improved ileal conduit surgery for bladder cancer with fewer complicationsZhiyong Li0Zhuowei Liu1Kai Yao2Zike Qin3Hui Han4Yonghong Li5Pei Dong6Yunlin Ye7Yanjun Wang8Zhiming Wu9Zhiling Zhang10Fangjian Zhou11Department of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterAbstract Background Radical cystectomy and urinary diversion remains the standard surgical treatment for patients with muscle-invasive or high-risk or recurrent non-muscle-invasive bladder cancer. Although this approach prolongs patient survival remarkably, there are postoperative complications associated with urinary diversion. This study aimed to assess the efficacy of modified ileal conduit surgery for reducing early and late stoma- and ureteroileal anastomosis-related complications, as compared with conventional ileal conduit urinary diversion. Methods We retrospectively evaluated the clinical data of bladder cancer patients treated with radical cystectomy and ileal conduit urinary diversion at Sun Yat-sen University Cancer Center between January 1, 2000 and June 30, 2016. Ileal conduit was created by the conventional or a modified technique. The clinicopathologic features of the conventional and the modified ileal conduit groups were compared using the t test and the Chi square test. Multivariable logistic regression analysis and multivariable Cox regression analysis were performed to determine the odds of developing stoma- and ureteroileal anastomosis-related complications in the two groups. Results 145 and 100 patients underwent the modified and conventional ileal conduit surgery, respectively. The two groups were comparable with regard to clinicopathologic features. The rate of stoma-related complications was significantly lower in the modified ileal conduit group than in the conventional ileal conduit group (0.7% vs. 17.0%, P < 0.001). No late stoma-related complications were seen in the modified ileal conduit group, but were seen in 13 (13.0%) patients in the conventional ileal conduit group. The rate of ureteroileal anastomosis-related complications was significantly lower in the modified ileal conduit group than in the conventional ileal conduit group (4.8% vs. 15.0%, P = 0.001). In multivariable analyses, the modified ileal conduit group was significantly less likely to develop stoma- (odds ratio [OR] = 0.024, 95% confidence interval [CI] 0.003–0.235; P = 0.001) or ureteroileal anastomosis-related complications (OR = 0.141, 95% CI 0.042–0.476; P = 0.002) than the conventional ileal conduit group. Conclusions Our modified surgical technique for ileal conduit urinary diversion may be effective for reducing early and late complications related to the stoma and the ureteroileal anastomosis. Prospective randomized clinical trials are needed to confirm our results.http://link.springer.com/article/10.1186/s40880-019-0366-8Bladder cancerCystectomyUrinary diversionIleal conduitComplicationSurgical technique
spellingShingle Zhiyong Li
Zhuowei Liu
Kai Yao
Zike Qin
Hui Han
Yonghong Li
Pei Dong
Yunlin Ye
Yanjun Wang
Zhiming Wu
Zhiling Zhang
Fangjian Zhou
An improved ileal conduit surgery for bladder cancer with fewer complications
Cancer Communications
Bladder cancer
Cystectomy
Urinary diversion
Ileal conduit
Complication
Surgical technique
title An improved ileal conduit surgery for bladder cancer with fewer complications
title_full An improved ileal conduit surgery for bladder cancer with fewer complications
title_fullStr An improved ileal conduit surgery for bladder cancer with fewer complications
title_full_unstemmed An improved ileal conduit surgery for bladder cancer with fewer complications
title_short An improved ileal conduit surgery for bladder cancer with fewer complications
title_sort improved ileal conduit surgery for bladder cancer with fewer complications
topic Bladder cancer
Cystectomy
Urinary diversion
Ileal conduit
Complication
Surgical technique
url http://link.springer.com/article/10.1186/s40880-019-0366-8
work_keys_str_mv AT zhiyongli animprovedilealconduitsurgeryforbladdercancerwithfewercomplications
AT zhuoweiliu animprovedilealconduitsurgeryforbladdercancerwithfewercomplications
AT kaiyao animprovedilealconduitsurgeryforbladdercancerwithfewercomplications
AT zikeqin animprovedilealconduitsurgeryforbladdercancerwithfewercomplications
AT huihan animprovedilealconduitsurgeryforbladdercancerwithfewercomplications
AT yonghongli animprovedilealconduitsurgeryforbladdercancerwithfewercomplications
AT peidong animprovedilealconduitsurgeryforbladdercancerwithfewercomplications
AT yunlinye animprovedilealconduitsurgeryforbladdercancerwithfewercomplications
AT yanjunwang animprovedilealconduitsurgeryforbladdercancerwithfewercomplications
AT zhimingwu animprovedilealconduitsurgeryforbladdercancerwithfewercomplications
AT zhilingzhang animprovedilealconduitsurgeryforbladdercancerwithfewercomplications
AT fangjianzhou animprovedilealconduitsurgeryforbladdercancerwithfewercomplications
AT zhiyongli improvedilealconduitsurgeryforbladdercancerwithfewercomplications
AT zhuoweiliu improvedilealconduitsurgeryforbladdercancerwithfewercomplications
AT kaiyao improvedilealconduitsurgeryforbladdercancerwithfewercomplications
AT zikeqin improvedilealconduitsurgeryforbladdercancerwithfewercomplications
AT huihan improvedilealconduitsurgeryforbladdercancerwithfewercomplications
AT yonghongli improvedilealconduitsurgeryforbladdercancerwithfewercomplications
AT peidong improvedilealconduitsurgeryforbladdercancerwithfewercomplications
AT yunlinye improvedilealconduitsurgeryforbladdercancerwithfewercomplications
AT yanjunwang improvedilealconduitsurgeryforbladdercancerwithfewercomplications
AT zhimingwu improvedilealconduitsurgeryforbladdercancerwithfewercomplications
AT zhilingzhang improvedilealconduitsurgeryforbladdercancerwithfewercomplications
AT fangjianzhou improvedilealconduitsurgeryforbladdercancerwithfewercomplications